Provided by Tiger Fintech (Singapore) Pte. Ltd.

CINGULATE INC.

4.24
+0.06001.44%
Post-market: 4.240.00000.00%19:33 EDT
Volume:61.15K
Turnover:252.95K
Market Cap:15.98M
PE:-0.42
High:4.27
Open:4.20
Low:4.04
Close:4.18
Loading ...

Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025

GlobeNewswire
·
04 Mar

Cingulate Inc - Charge Against CEO Schaffer Dismissed

THOMSON REUTERS
·
04 Feb

Cingulate Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
30 Jan

Cingulate price target adjusted to $20 from $8 at H.C. Wainwright

TIPRANKS
·
30 Jan

Roth MKM Starts Cingulate With Buy Rating, $12 Price Target

MT Newswires Live
·
10 Jan

Cingulate initiated with a Buy at Roth MKM

TIPRANKS
·
10 Jan

“Buy Rating for Cingulate Inc.: Promising Phase 3 Data and Strong Financial Outlook”

TIPRANKS
·
10 Jan

Cingulate Inc’s Promising Market Positioning and Accelerated Path to Market Entry for CTx-1301

TIPRANKS
·
08 Jan

BRIEF-Cingulate Inc Final Study Completed For Cingulate's Lead Asset Ctx-1301

Reuters
·
07 Jan

Cingulate Inc: Submission of New Drug Application Targeted for Mid 2025

THOMSON REUTERS
·
07 Jan

Cingulate Inc: Final Study Completed for Cingulate's Lead Asset Ctx-1301

THOMSON REUTERS
·
07 Jan

Cingulate Inc: No Serious Adverse Events Reported

THOMSON REUTERS
·
07 Jan

Final Study Completed for Cingulate’s Lead Asset CTx-1301

GlobeNewswire
·
07 Jan

Cingulate's Shares Rise After $5 Million Capital Raise

MT Newswires Live
·
24 Dec 2024

Cingulate Inc Secures $5M Financing for Strategic Growth

TIPRANKS
·
23 Dec 2024

Cingulate completes financing transaction for net proceeds of $5M

TIPRANKS
·
23 Dec 2024

Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000

THOMSON REUTERS
·
23 Dec 2024

Press Release: Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000

Dow Jones
·
23 Dec 2024

Cingulate Raised to Buy From Hold by Maxim Group

Dow Jones
·
21 Nov 2024

Maxim Group Upgrades Cingulate to Buy From Neutral, $8 Price Target

MT Newswires Live
·
20 Nov 2024